Lab Rats series: A Bengaluru startup’s bid to drug the undruggable
Backed by an ₹86 crore government grant and ₹70 crore Series A funding, Peptris Technologies is leveraging generative AI to build a preclinical pipeline targeting rare diseases and previously undruggable proteins.
Mint asks for a subscription to read the full story. If you have one, sign in on their site.
0 comments